Mitoxantrone for multiple sclerosis
Filippo Martinelli Boneschi(Ollscoil na Gaillimhe – University of Galway), Giancarlo Comi(Vita-Salute San Raffaele University), Laura Vacchi(Neuroscience Institute), Ruggero Capra(Presidio Ospedaliero), Marco Rovaris(San Raffaele University of Rome)
Cited by 157
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
|New England Journal of Medicine|2016|1.9k